AHCPR/DuPont Merck collaboration for Coumadin use in stroke prevention is agency's first with private sector.
Executive Summary
DUPONT MERCK/AHCPR STROKE PREVENTION STUDY COLLABORATION will involve a three-year intervention study in managed care organizations to assess educational efforts aimed at physicians and patients on the appropriate use of the company's anticoagulant warfarin (Coumadin). Agency for Health Care Policy & Research Administrator Clifton Gaus unveiled the agreement, the HHS agency's first formal partnership with the private sector, at an April 30 press conference in Washington, D.C.